> The FDA has approved Kyprolis for combo use in the treatment of patients with relapsed multiple myeloma. Release
> Bristol-Myers Squibb's ($BMY) hep C pill, Daklinza, has won FDA approval to be used in combination with Gilead's ($GILD) Sovaldi. Release
> AstraZeneca ($AZN) has inked a $300 million pact to sell thyroid carcinoma drug Caprelsa to Sanofi's ($SNY) Genzyme. Story
> After the close of Teva's ($TEVA) $40.5 billion deal for Allergan's generics business, the Israeli drugmaker will boast a commercial presence in 100 markets, including a top-three position in more than 40 of those markets, it said Monday. Release
And Finally... Television's Dr. Oz made $1.17 million off a hemorrhoid treatment he promoted in his column, Vox reports. More